Form 13-F position report

BIOATLA INC

Reported by VANGUARD GROUP INC

BCAB CUSIP 09077B104 Manager CIK 0000102909

Reported 1,945,795 shares, unchanged from the prior quarter.

Reported value -17.4%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q4 2025
Shares 1,945,795 Quarter-end amount reported
Reported value $1,105,212 Fair value at quarter end
Consecutive quarters held 21 Through Q4 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-03-31 51048000
2021-06-30 44410000
2021-09-30 61501000
2021-12-31 44454000
2022-03-31 7782000
2022-06-30 3262000
2022-09-30 10843000
2022-12-31 15931072
2023-03-31 5154645
2023-06-30 6293100
2023-09-30 3573937
2023-12-31 5120171
2024-03-31 7220687
2024-06-30 2582795
2024-09-30 3318044
2024-12-31 1082993
2025-03-31 630846
2025-06-30 706126
2025-09-30 1338707
2025-12-31 1105212

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOATLA INC held by VANGUARD GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Unchanged 1,945,795 0 (0.0%) < 0.01% $1,105,212 2026-01-29
Q3 2025 Added 1,945,795 +162,647 (9.1%) < 0.01% $1,338,707 2025-11-07
Q2 2025 Reduced 1,783,148 -34,854 (-1.9%) < 0.01% $706,126 2025-08-11
Q1 2025 Reduced 1,818,002 -14,474 (-0.8%) < 0.01% $630,846 2025-05-09
Q4 2024 Reduced 1,832,476 -52,776 (-2.8%) < 0.01% $1,082,993 2025-02-11
Q3 2024 Unchanged 1,885,252 0 (0.0%) < 0.01% $3,318,044 2024-11-13
Q2 2024 Reduced 1,885,252 -213,785 (-10.2%) < 0.01% $2,582,795 2024-08-13
Q1 2024 Added 2,099,037 +17,667 (0.8%) < 0.01% $7,220,687 2024-05-10
Q4 2023 Reduced 2,081,370 -20,946 (-1.0%) < 0.01% $5,120,171 2024-02-14
Q3 2023 Added 2,102,316 +4,616 (0.2%) < 0.01% $3,573,937 2023-11-14
Q2 2023 Added 2,097,700 +174,325 (9.1%) < 0.01% $6,293,100 2023-08-14
Q1 2023 Reduced 1,923,375 -7,664 (-0.4%) < 0.01% $5,154,645 2023-05-15
Q4 2022 Added 1,931,039 +522,807 (37.1%) < 0.01% $15,931,072 2023-02-10
Q3 2022 Added 1,408,232 +263,597 (23.0%) < 0.01% $10,843,000 2022-11-14
Q2 2022 Reduced 1,144,635 -411,647 (-26.5%) < 0.01% $3,262,000 2022-08-12
Q1 2022 Reduced 1,556,282 -708,372 (-31.3%) < 0.01% $7,782,000 2022-05-13
Q4 2021 Added 2,264,654 +175,631 (8.4%) < 0.01% $44,454,000 2022-02-14
Q3 2021 Added 2,089,023 +1,041,111 (99.4%) < 0.01% $61,501,000 2021-11-12
Q2 2021 Added 1,047,912 +43,841 (4.4%) < 0.01% $44,410,000 2021-08-13
Q1 2021 Added 1,004,071 +929,071 (1238.8%) < 0.01% $51,048,000 2021-05-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

48 managers reported BIOATLA INC for Q4 2025.

Managers reporting BIOATLA INC in Q4 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ACORN CAPITAL ADVISORS LLC Unchanged 4,835,111 0 0.93% $2,756,013 5 qtrs
VANGUARD GROUP INC This report Unchanged 1,945,795 0 < 0.01% $1,105,212 21 qtrs
MARSHALL WACE LLP New 891,580 +891,580 < 0.01% $508,201 6 qtrs
MILLENNIUM MANAGEMENT LLC Added 762,394 +421,072 < 0.01% $432,811 21 qtrs
ACADIAN ASSET MANAGEMENT LLC Reduced 757,671 -172,791 < 0.01% $429,000 9 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 707,214 -93,417 < 0.01% $401,485 17 qtrs
DEUTSCHE BANK AG Unchanged 525,353 0 < 0.01% $299,451 20 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 500,328 +5,117 < 0.01% $284,096 21 qtrs
BlackRock Inc Unchanged 480,933 0 < 0.01% $273,026 6 qtrs
JANE STREET GROUP LLC Added 346,774 +152,397 < 0.01% $196,863 20 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2025
Filed
January 29, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
279,908
None
1,665,887

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.